A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis
- Rivista
- Head & Face Medicine
- Autori
- Campisi G, Mauceri R, Bertoldo F, Fusco V, Bedogni A
- Citazione bibliografica
- 2021 Jul 9;17(1):25
- DOI
- 10.1186/s13005-021-00280-4